This article has an addendum: Research funding was obtained from the Albany College of Pharmacy and Health Sciences, Scholarship of Discovery Fund.
Original article: Oncotarget. 2023; 14:284–293. 284-293. https://doi.org/10.18632/oncotarget.28397
. 2023 Sep 15;14:810. doi: 10.18632/oncotarget.28507
Addendum: Crosstalk between triple negative breast cancer and microenvironment
Karly Smrekar
1, Artem Belyakov
1, Kideok Jin
1,✉
Karly Smrekar
1Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Science, Albany, NY 12208, USA
Find articles by Karly Smrekar
Artem Belyakov
1Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Science, Albany, NY 12208, USA
Find articles by Artem Belyakov
Kideok Jin
1Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Science, Albany, NY 12208, USA
Find articles by Kideok Jin
1Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Science, Albany, NY 12208, USA
✉
Correspondence to: Kideok Jin, email : kideok.jin@acphs.edu
Collection date 2023.
Copyright: © 2023 Smrekar et al.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PMCID: PMC10503740 PMID: 37713335
See "Crosstalk between triple negative breast cancer and microenvironment" on page 284.